BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23917280)

  • 21. Returning pleiotropic results from genetic testing to patients and research participants.
    Kocarnik JM; Fullerton SM
    JAMA; 2014 Feb; 311(8):795-6. PubMed ID: 24481117
    [No Abstract]   [Full Text] [Related]  

  • 22. Currents in contemporary bioethics. Identifying consanguinity through routine genomic analysis: reporting requirements.
    McGuire AL; Wang MJ; Probst FJ
    J Law Med Ethics; 2012; 40(4):1040-6. PubMed ID: 23289705
    [No Abstract]   [Full Text] [Related]  

  • 23. The Role of Whole Genome and Whole Exome Sequencing in Preventive Genomic Sequencing Programs.
    Bertier G; Zawati MH; Joly Y
    Am J Bioeth; 2015; 15(7):22-4. PubMed ID: 26147258
    [No Abstract]   [Full Text] [Related]  

  • 24. Preventive Genomic Sequencing and Care of the Individual Patient.
    Char D
    Am J Bioeth; 2015; 15(7):32-3. PubMed ID: 26147263
    [No Abstract]   [Full Text] [Related]  

  • 25. Double Trouble: Preventive Genomic Sequencing and the Case of Minors.
    Hens K; Dierickx K
    Am J Bioeth; 2015; 15(7):30-1. PubMed ID: 26147262
    [No Abstract]   [Full Text] [Related]  

  • 26. Preventive Genomic Sequencing in the General Population: Do PGS Fly?
    Cho MK
    Am J Bioeth; 2015; 15(7):1-2. PubMed ID: 26147253
    [No Abstract]   [Full Text] [Related]  

  • 27. Patient Choice and Preventive Genomic Sequencing--More Trouble Upstream.
    Holm S; Ploug T
    Am J Bioeth; 2015; 15(7):24-6. PubMed ID: 26147259
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidental findings in medical imaging and genetic testing: opportunities and challenges.
    Erickson LA
    Mayo Clin Proc; 2014 Jun; 89(6):715-7. PubMed ID: 24943690
    [No Abstract]   [Full Text] [Related]  

  • 29. Models of consent to return of incidental findings in genomic research.
    Appelbaum PS; Parens E; Waldman CR; Klitzman R; Fyer A; Martinez J; Price WN; Chung WK
    Hastings Cent Rep; 2014; 44(4):22-32. PubMed ID: 24919982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in Conceptual Understanding of the "Actionability" of Incidental Findings and the Resultant Difference in Ethical Responsibility: An Empirical Study in Japan.
    Ibuki T; Yamamoto K; Matsui K
    AJOB Empir Bioeth; 2020; 11(3):187-194. PubMed ID: 32615058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing the ethical challenges of next-generation sequencing in genomic medicine.
    Clarke AJ
    Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic medicine and incidental findings: it is more complicated than deciding whether to disclose or not.
    Crawford G; Foulds N; Fenwick A; Hallowell N; Lucassen A
    Genet Med; 2013 Nov; 15(11):896-9. PubMed ID: 24091799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choices of incidental findings of individuals undergoing genome wide sequencing, a single center's experience.
    Bishop CL; Strong KA; Dimmock DP
    Clin Genet; 2017 Jan; 91(1):137-140. PubMed ID: 27392285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidentalomas in genomics and radiology.
    Solomon BD
    N Engl J Med; 2014 Mar; 370(11):988-90. PubMed ID: 24620864
    [No Abstract]   [Full Text] [Related]  

  • 35. Freedom of Choice About Incidental Findings Can Frustrate Participants' True Preferences.
    Viberg J; Segerdahl P; Langenskiöld S; Hansson MG
    Bioethics; 2016 Mar; 30(3):203-9. PubMed ID: 25908209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disclosure of Misattributed Paternity.
    Prero MY; Strenk M; Garrett J; Kessler A; Fanaroff JM; Lantos JD
    Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31097466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adolescents' preferences regarding disclosure of incidental findings in genomic sequencing that are not medically actionable in childhood.
    Hufnagel SB; Martin LJ; Cassedy A; Hopkin RJ; Antommaria AH
    Am J Med Genet A; 2016 Aug; 170(8):2083-8. PubMed ID: 27149544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing incidental genomic findings: legal obligations of clinicians.
    Clayton EW; Haga S; Kuszler P; Bane E; Shutske K; Burke W
    Genet Med; 2013 Aug; 15(8):624-9. PubMed ID: 23448723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring concordance and discordance for return of incidental findings from clinical sequencing.
    Green RC; Berg JS; Berry GT; Biesecker LG; Dimmock DP; Evans JP; Grody WW; Hegde MR; Kalia S; Korf BR; Krantz I; McGuire AL; Miller DT; Murray MF; Nussbaum RL; Plon SE; Rehm HL; Jacob HJ
    Genet Med; 2012 Apr; 14(4):405-10. PubMed ID: 22422049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to Open Peer Commentaries on "Looking for Trouble: Preventive Genomic Sequencing in the General Population and the Role of Patient Choice".
    Lázaro-Muñoz G; Conley JM; Davis AM; Van Riper M; Walker RL; Juengst ET
    Am J Bioeth; 2015; 15(12):W6-9. PubMed ID: 26632375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.